Skip to content

A study in healthy people to test how Zongertinib is taken up in the body when given as tablets made by two different manufacturers with or without food

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-525696-77-00
Enrollment
56
Registered
2026-08-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Interventions

None listed

Sponsors

Boehringer Ingelheim International GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Aug 8, 2026